Pharmacovigilance in the pharmaceutical industry

被引：36

作者：

Talbot, JCC

Nilsson, BS

机构：

[1] Astra Charnwood, Pharmacovigilance, Loughborough LE11 5RH, Leics, England

[2] Astra Res Ctr AB, Clin Drug Safety, S-15185 Sodertalje, Sweden

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1998年 / 45卷 / 05期

关键词：

adverse drug reactions; adverse events; drug safety; pharmaceutical industry; pharmacoepidemiology; pharmacovigilance; risk-benefit;

D O I：

10.1046/j.1365-2125.1998.00713.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：427 / 431

页数：5

共 22 条

[1]

ARNOLD B, 1997, DRUG INF J, V31, P181

[2]

*CIOMS, 1995, WORK GROUP 3 GUID PR

[3]

*CSM MCA, 1993, CURRENT PROBLEMS PHA, V19, P1

[4]

D'Arcy PF, 1996, P 3 INT C HARM YOK 1

[5] Concepts in risk-benefit assessment - A simple merit analysis of a medicine? [J].

Edwards, IR ;

Wiholm, BE ;

Martinez, C .

DRUG SAFETY, 1996, 15 (01) :1-7

[6] Population-based study of risk of venous thromboembolism associated with various oral contraceptives [J].

Farmer, RDT ;

Lawrenson, RA ;

Thompson, CR ;

Kennedy, JG ;

Hambleton, IR .

LANCET, 1997, 349 (9045) :83-88

[7] Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis [J].

Henry, D ;

Lim, LLY ;

Rodriguez, LAG ;

Gutthann, SP ;

Carson, JL ;

Griffin, M ;

Savage, R ;

Logan, R ;

Moride, Y ;

Hawkey, C ;

Hill, S ;

Fries, JT .

BRITISH MEDICAL JOURNAL, 1996, 312 (7046) :1563-1566

[8]

KRISTOFFERSSON A, 1989, AUTOIMMUNITY TOXICOL, P183

[9] COMPUTER-ASSISTED EVALUATION OF ADVERSE EVENTS USING A BAYESIAN-APPROACH [J].

LANCTOT, KL ;

NARANJO, CA .

JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (02) :142-147

[10] The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research [J].

Lewis, MA ;

Heinemann, LAJ ;

MacRae, KD ;

Bruppacher, R ;

Spitzer, WO .

CONTRACEPTION, 1996, 54 (01) :5-13

← 1 2 3 →